ILC 2021 is all about beating liver disease together. Attendees tackle this challenge from multiple perspectives, drawing on multidisciplinary expertise while broadening their knowledge and building bridges between people and areas of expertise.

Don’t miss Carelon Research’s latest liver disease research at this virtual flagship congress. Registration is required to view presentations. For more information, go to https://easl.eu/event/the-international-liver-congress-2021 .

Carelon Research presentations

Carelon Research authors are indicated in bold. Asterisk indicates Carelon Research associate at the time of submission.

Presentation

Title

Authors

Affiliations

Poster Presentation

Wednesday, June 23, 2021
08:00 – 18:00 CET

PO-980 | Incidence Rates of Hepatobiliary Outcomes among Patients with Non-alcoholic Steatohepatitis Based on Fibrosis-4 Score Severity at Baseline

Titievsky L1, Jamal-Allial A2, Gallagher K2, Capozza T1, Dodge S1, Du S2*, Law A1, Natha M1, Ness E1, Nguyen M3, Patel Y4, Randhawa A1, Esposito D2*

1Intercept, New York, NY, 2Carelon Research, Watertown, MA, 3Stanford University, Redwood City, CA, 4Duke University, Durham, NC

Poster Presentation

Wednesday, June 23, 2021
08:00 – 18:00 CET

PO-1588 | Comorbidity and Healthcare Utilization Burden of Patients Diagnosed with Non-alcoholic Steatohepatitis Based on Fibrosis-4 Score Severity

Titievsky L1, Jamal-Allial A2, Gallagher K2, Capozza T1, Dodge S1, Du S2*, Law A1, Natha M1, Ness E1, Nguyen M3, Patel Y4, Randhawa A1, Esposito D2*

1Intercept, New York, NY, 2Carelon Research, Watertown, MA, 3Stanford University, Redwood City, CA, 4Duke University, Durham, NC

Ready to learn more? Let's connect.